SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
Certification and Notice of Termination of Registration under Section 12(g)
of the Securities Exchange Act of 1934 or Suspension of Duty to File Reports
Under Sections 13 and 15(d) of the Securities Exchange Act of 1934
Commission File Number: 001-10600
MAXXIM MEDICAL, INC.
(Exact name of registrant as specified in its charter)
10300 49th Street North
Clearwater, Florida 33762
(727) 561-2100
(Address, including zip code and telephone number, including area code,
of registrant's principal executive offices)
Common Stock, par value $.001 per share
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a
duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) [X] Rule 12h-3(b)(1)(ii) [ ]
Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(2)(i) [ ]
Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(ii) [ ]
Rule 12g-4(a)(2)(ii) [ ] Rule 15d-6 [ ]
Rule 12h-3(b)(1)(i) [X]
Approximate number of holders of record as of the certification
or notice date: 19
Pursuant to the requirements of the Securities Exchange Act of 1934,
Maxxim Medical, Inc. has caused this certification/notice to be signed on its
behalf by the undersigned duly authorized person.
MAXXIM MEDICAL, INC., a Texas corporation
DATE: November 12, 1999 By: /s/ Alan S. Blazei
----------------------------------------
Name: Alan S. Blazei
Title: Executive Vice President
and Controller
